Two common blood pressure meds fare equally in preventing heart woes

2 common blood pressure meds fare equally in preventing heart woes
Review shows no difference between atenolol, metoprolol in warding off heart attack or stroke.

(HealthDay)—In a review that compared two common heart drugs against each other, researchers found no difference between atenolol and metoprolol in terms of preventing stroke, heart attack or heart failure for patients with high blood pressure who were placed on the medications.

Atenolol (Tenormin) and metoprolol tartrate (Lopressor) are beta blockers that are widely used to treat high blood pressure and . Previous research has suggested that atenolol might be less effective than other high for preventing cardiovascular events in patients with high blood pressure.

In this study, researchers reviewed the medical records of nearly 121,000 U.S. patients with high blood pressure but no history of heart disease who started taking one of the two drugs between 2000 and 2009. Atenolol was used by about 10 times more patients than metoprolol.

During a follow-up averaging about five years, there was no statistically significant difference in rates of heart attack, stroke or heart failure between the two groups of patients.

"In conclusion, we found no differences in [heart] event rates ... with either atenolol or metoprolol," said review author Emily Parker, of HealthPartners Institute for Education and Research in Minneapolis, and colleagues. However, the researchers added that the findings "should be interpreted cautiously, since there have been no trials comparing these two beta blockers directly."

Two experts not connected to the study said patients have many options for treating high blood pressure.

"Like many of my colleagues, I also use beta blockers as an add-on antihypertensive strategy for those patients being treated for hypertension and not yet having other ," said Dr. David Friedman, chief of services at North Shore-LIJ's Plainview Hospital, in Plainview, N.Y. He added, however, that "when it comes to treating blood pressure alone, have taken a back seat to other medications such as diuretics."

Dr. Kenneth Ong is acting chair of the department of medicine and cardiology at The Brooklyn Hospital Center, in New York City. He noted that there has been debate as to whether atenolol works as well as other drugs used to fight .

"While the [new] study is a retrospective analysis, it suggests that there may be no merit to changing atenolol to metoprolol tartrate," he said. "It will be important to verify these findings with a randomized, prospective trial."

The review was funded by the U.S. National Heart, Lung and Blood Institute, and was published online Aug. 27 in the Archives of Internal Medicine.

More information: The U.S. National Heart, Lung, and Blood Institute has more about treatment of high blood pressure.

add to favorites email to friend print save as pdf

Related Stories

Blood pressure drugs don't protect against colorectal cancer

May 14, 2012

A new study has found that, contrary to current thinking, taking beta blockers that treat high blood pressure does not decrease a person's risk of developing colorectal cancer. Published early online in CANCER, a peer-reviewed journa ...

Heart failure treated 'in the brain'

Mar 25, 2008

Beta-blockers heal the heart via the brain when administered during heart failure, according to a new study by UCL (University College London). Up to now, it was thought that beta-blockers work directly on the heart, but ...

Take your blood pressure meds before bed

Oct 24, 2011

It's better to take blood pressure-lowering medications before bed rather than first thing in the morning, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results i ...

FDA approves a new beta blocker

Dec 18, 2007

The U.S. Food and Drug Administration has approved Bystolic, a beta blocker, for the treatment of high blood pressure. Bystolic (nebivolol) is a new drug not previously approved for use in the United States.

Recommended for you

Barriers preventing post-stroke care

Jul 24, 2014

For stroke victims, rehabilitation is crucial to their recovery. But a Flinders University study conducted in Singapore found that rehabilitation rates following discharge from hospital are poor because of gaps in the continuum ...

Home-based rehabilitation for CVD patients

Jul 24, 2014

Patients who are found to suffer from cardiovascular diseases often have long years of treatment ahead of them and are urged to drastically change their lifestyle. But what is probably the most difficult ...

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

tpb
not rated yet Aug 28, 2012
"During a follow-up averaging about five years, there was no statistically significant difference in rates of heart attack, stroke or heart failure between the two groups of patients."

Perhaps neither drug had any effect at all.